MERCK & CO. INC. (MRK) Stock Price, Quote, News and Summary
NYSE:MRK - New York Stock Exchange, Inc. - US58933Y1055 - Common Stock
MRK Quote and Key Statistics
MERCK & CO. INC.
NYSE:MRK (1/17/2025, 8:15:56 PM)
Premarket: 98.19 +0.27 (+0.28%)97.92
-2.78 (-2.76%)
MRK Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.23% | ||
| ROA | 10.34% | ||
| ROE | 27.3% | ||
| Debt/Equity | 0.79 |
MRK Performance and Technical Analysis
MRK Ownership and Analysts
MRK Latest News and Analysis
What's going on in today's session: S&P500 movers
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Friday.
What's going on in today's session: S&P500 movers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.
Is NYSE:MRK suited for dividend investing?
Uncovering Dividend Opportunities with MERCK & CO. INC. (NYSE:MRK).
NYSE:MRK: good value for what you're paying.
Don't overlook MERCK & CO. INC. (NYSE:MRK)—it's a hidden gem with strong fundamentals and an attractive price tag.
Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
Friday Sector Laggards: Utilities, Healthcare
About MRK
Company Profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 72,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Human health vaccine products consist of preventive pediatric, adolescent and adult vaccines. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company is also engaged in developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine methyl transferase.
Company Info
MERCK & CO. INC.
126 East Lincoln Avenue
Rahway NEW JERSEY 07033 US
CEO: Kenneth C. Frazier
Employees: 71000
Company Website: https://www.merck.com/
Investor Relations: https://www.merck.com/investor-relations
Phone: 19087404000
MRK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 71.36 | 688.94B | ||
| JNJ | JOHNSON & JOHNSON | 14.36 | 353.99B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 26.77 | 349.49B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.48 | 206.53B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.07 | 194.99B | ||
| PFE | PFIZER INC | 10.19 | 149.04B | ||
| SNY | SANOFI-ADR | 12.26 | 127.21B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.11 | 114.17B | ||
| ZTS | ZOETIS INC | 28.8 | 74.84B | ||
| GSK | GSK PLC-SPON ADR | 8.21 | 68.21B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.53 | 40.96B | ||
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 7.88 | 24.83B |